Markets

Stock Alert: Biomerica Down 30%

(RTTNews) - Shares of Biomerica Inc. (BMRA) are slipping 30% on Friday morning after the medical products maker reported third-quarter results.

BMRA is currently trading $5.00, down $2.29 or 31.41%, on the Nasdaq.

Sales for the third quarter dropped to $1.14 million from $1.19 million a year ago. Net loss was $1.6 million, wider than last year's loss of $0.5 million.

Research and Development expense increased 80% to $0.7 million largely due to the development of several COVID-19 tests, including a new antigen test for COVID-19.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

BMRA

Latest Markets Videos

    RTTNews

    Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.

    Learn More